Evidence map›Paper›PMID 36171757›Full record

ArticleFrontiers in cellular and infection microbiology2022

Dengue activates mTORC2 signaling to counteract apoptosis and maximize viral replication.

Christoph C Carter, Fred D Mast, Jean Paul Olivier, Natasha M Bourgeois, Alexis Kaushansky, John D Aitchison

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Multiple receptor tyrosine kinases regulate dengue infection of hepatocytes.Frontiers in cellular and infection microbiology · 2024
    Article
  9. Cognitive Impairment in Multiple Sclerosis.Bioengineering (Basel, Switzerland) · 2023
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Christoph C CarterCenter for Infectious Disease Research, Seattle, WA, United States.
Fred D MastCenter for Infectious Disease Research, Seattle, WA, United States.
Jean Paul OlivierCenter for Infectious Disease Research, Seattle, WA, United States.
Natasha M BourgeoisCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, United States.
Alexis KaushanskyCenter for Infectious Disease Research, Seattle, WA, United States.
John D AitchisonCenter for Infectious Disease Research, Seattle, WA, United States.
Center for Infectious Disease Research · USInfectious Disease Research Institute · USUniversity of Washington · US

Funding

TR&D Project 4. The Imaging Stage: Multiscale Spatiotemporal Modeling of Macromolecular Systems in Cellular NeighborhoodsP41GM109824 · NIGMS · ROCKEFELLER UNIVERSITY · PI ROUT, MICHAEL P · 2014 to 2023
$18.8M
HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
Perturbations of host cell signaling by a complex hepatotropic pathogenR01GM101183 · NIGMS · SEATTLE CHILDREN'S HOSPITAL · PI KAUSHANSKY, ALEXIS · 2013 to 2021
$3.6M
Applying the principle of synthetic lethality to virus-host protein-protein interactions as a novel approach for antiviral developmentR21AI124266 · NIAID · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI AITCHISON, JOHN D. · 2016 to 2017
$520k
CIHRNIAID NIH HHS R21 AI124266NIAID NIH HHS T32 AI007044NIAID NIH HHS T32 AI007509NIGMS NIH HHS P41 GM109824NIGMS NIH HHS R01 GM101183
6 · The paper itself

Abstract

The mechanistic target of rapamycin (mTOR) functions in two distinct complexes: mTORC1, and mTORC2. mTORC1 has been implicated in the pathogenesis of flaviviruses including dengue, where it contributes to the establishment of a pro-viral autophagic state. Activation of mTORC2 occurs upon infection with some viruses, but its functional role in viral pathogenesis remains poorly understood. In this study, we explore the consequences of a physical protein-protein interaction between dengue non-structural protein 5 (NS5) and host cell mTOR proteins during infection. Using shRNA to differentially target mTORC1 and mTORC2 complexes, we show that mTORC2 is required for optimal dengue replication. Furthermore, we show that mTORC2 is activated during viral replication, and that mTORC2 counteracts virus-induced apoptosis, promoting the survival of infected cells. This work reveals a novel mechanism by which the dengue flavivirus can promote cell survival to maximize viral replication.

Indexed as

DengueMultiprotein ComplexesApoptosisHumansMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2RNA, Small InterferingSirolimusTOR Serine-Threonine KinasesVirus ReplicationMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2Multiprotein ComplexesRNA, Small InterferingSirolimusTOR Serine-Threonine Kinasesapoptosisdengue virus (DENV)flavivirusmechanistic target of rapamycin complex 2 (mTORC2)mechanistic target of rapamycin (mTOR)non-structural protein 5pathogenesisviral replication

Identifiers

PMID36171757
PMCPMC9510660
OpenAlexW4296523967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.